COLUMBUS, OH – April 8, 2025 – The Ohio Life Sciences Association (OLS) applauds the National Security Commission on Emerging Biotechnology (NSCEB) for its leadership and vision in publishing its final report and action plan to Congress. This comprehensive roadmap is a vital step toward securing and advancing U.S. leadership in biotechnology at a critical moment for our nation’s competitiveness, security, and economic future.
We strongly support the Commission’s call for urgent federal action, including the proposed $15 billion in new investments over five years, to ensure the U.S. biotechnology sector remains the global leader in innovation and commercialization. These resources will help drive transformative advances across healthcare, manufacturing, national security, and more.
The timing of this report is especially critical as our nation’s life sciences research and innovation infrastructure, particularly at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) faces considerable uncertainty. Strong federal leadership and investment are essential to maintain the momentum of discovery, innovation, and public health progress.
The report’s 49 recommendations, organized across six strategic pillars, offer a bold and actionable framework:
- Prioritize biotechnology at the national level
- Mobilize the private sector to get U.S. products to scale
- Maximize the benefits of biotechnology for defense
- Out-innovate our strategic competitors
- Build the biotechnology workforce of the future
- Mobilize the collective strengths of our allies and partners
Ohio Life Sciences encourages members of the Ohio congressional delegation to endorse the Commission’s report and advocate for its swift and full implementation by the administration. Ohio’s leadership in life sciences innovation positions our state to be a key contributor in realizing the report’s vision, and federal support is essential to maximizing this opportunity for both regional and national impact.
As Ohio continues to grow its vibrant life sciences ecosystem, we recognize the immense potential of a coordinated national strategy to accelerate innovation, empower our workforce, and foster public-private partnerships. We look forward to working with policymakers, industry partners, and research institutions to implement these recommendations and deliver biotechnology solutions that improve lives and strengthen our country. As the report states, without this type of transformational investment, our adversaries will work to leverage their biotech advancements to attack, destroy, starve, and harm the U.S.
The full text of the Commission’s final report is available at: https://biotech.senate.gov
About Ohio Life Sciences
Ohio Life Sciences (OLS) is the statewide trade association representing and advocating for the life sciences community in Ohio. Our members span the medical device, biopharmaceutical, diagnostics, research, and digital health sectors, all working to improve health outcomes and drive economic growth across the state.
